Top doctor: Feds demonizing COVID-19 treatments in order to promote vaccine. National Institute of Health issued a guideline recommending physicians not treat COVID-19 until a patient needs oxygen.
Posted on
“Something has gone off the rails” in the world’s approach to the novel coronavirus pandemic, with health authorities in the U.S. and abroad suppressing safe, cheap and effective treatments while promoting experimental vaccines that have received only emergency use authorization, contends Dr. Peter McCullough.
McCullough, a renowned cardiologist who testified to U.S. Senate last fall on COVID-19 treatments, pointed out in a lengthy interview with Tucker Carlson’s Fox Nation show “Tucker Carlson Today” that the National Institutes of Health issued a guideline recommending physicians not treat COVID-19 until a patient needs oxygen.
Operator
Good afternoon. And welcome to Shockwave s first-quarter 2021 earnings conference call. [Operator instructions] As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Debbie Kaster, vice president of investor relations at Shockwave, for a few introductory comments.
Debbie Kaster
Vice President of Investor Relations
Thank you, all, for participating in today s call. Joining me today from Shockwave Medical are Doug Godshall, president and chief executive officer; Isaac Zacharias, chief commercial officer; and Dan Puckett, chief financial officer. Earlier today, Shockwave released financial results for the quarter ended March 31, 2021. A copy of the press release is available on Shockwave s website.
Amgen To Present Four Cardiovascular Research Abstracts
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) said Tuesday that it will present four cardiovascular research abstracts, including final data from the Repatha or evolocumab open label extension trial of patients living with HIV who have high cholesterol, as well as new data from FOURIER evaluating biomarkers of major cardiovascular events, including complex revascularization procedures.
The company will present additional abstracts, including a simulation comparing the impact of different LDL-C guidelines on CV risk reduction, as well as negative control outcomes to assess residual bias when comparing PCSK9 inhibitors to other treatments.
The company noted that it will present those analyses at the American College of Cardiology s 70th Annual Scientific Session & Expo (ACC.21), May 15-17, 2021.
Less Care for Young Women With Chest Pain in the Emergency n? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
May 11, 2021
Those flimsy, wallet-sized pieces of paper that detail the type, size, and location of the stent implanted? After roughly 4 years after device implantation, just under half of patients still carry their stent card, according to a new study.
And even among those diligent card-carrying members of the coronary stent club, patients had very little knowledge about the device propping open their arteries. In fact, only 17% of patients with a stent card were able to correctly identify the date of the procedure, the vessel stented, and the type of stent they received, say researchers.
For one cardiologist, the continued reliance on paper stent cards doesn’t make much sense. Computers, cellular phones, and app-based technology would go a long way toward eliminating the need for patients to carry around the card, especially since half aren’t doing so anyway.